Zhen (Lucy) Zhou (@zhenzhou11) header
Zhen (Lucy) Zhou (@zhenzhou11) profile picture

Postdoctoral fellow, School of Public Health and Preventive Medicine, Monash University, Melbourne Australia. Epidemiologist, major interest in primary care

Melbourne, Victoria
Joined June 2017
Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)Photo by Zhen (Lucy) Zhou (@zhenzhou11)
I had a great time with my colleagues on #AHA2024.
21
I am looking forward to presenting some interesting data of this study in the upcoming #AHA2024 conference. Join us for the session on Brain Health and Cerebrovascular disease starting at 8 am 17th.
Fluctuating Cholesterol Linked to Higher Dementia Risk A new study links fluctuating cholesterol levels in older adults to a heightened risk of dementia and cognitive decline. Researchers tracked nearly 10,000 older adults without dementia, finding that those with high year-to-year cholesterol variability were significantly more likely to develop dementia. Notably, changes in total and LDL cholesterol were associated with faster declines in memory and reaction speed. Researchers suggest that these fluctuations, even without medication changes, could destabilize blood vessel health in the brain, potentially impacting cognitive function. High cholesterol variability may serve as an early indicator for dementia, with potential for future therapies targeting cholesterol stability. These findings highlight the need for consistent monitoring of cholesterol levels as a part of cognitive health assessment.
44
We are extremely honored to receive the #AHA2024 Paul Dudley White International Scholar Award for the highest ranked abstract from Australia! This is the best testament to our team's hard work! @AHAMeetings @heartfoundation @Monash_SPHPM @aspree_org
1
27
Zhen (Lucy) Zhou retweeted
Implementation science should be considered early in development of CV treatments. This #JACC review describes improvements in trial design to foster post-trial implementation. bit.ly/40Ep19T #ClinicalTrials #CVD @hvanspall @ProfMensah
1
11
38
5,835
An important work from my team showing the safety of aspirin cessation in older adults publish in BMC Medicine. rdcu.be/dPTzs
1
1
36
Nice summary
It’s important to finish the job ‼️ 🔑 Don’t forget to assess & manage residual risk in our ASCVD 👥 See below for risk factors & relevant clinical trials 👇🏼 #cardiotwitter #MedTwitter #ACC2024 @ACCinTouch #MedEd @ErinMichos
51
Dr.Ratio is definitely my favor playable member ☺️ #HonkaiStaiRail #DrRatio
In the quest to give trailblazers access to a proper education, we invite you to participate in our Dr. Ratio giveaway event, with prizes including books hand-selected by the esteemed Veritas Ratio himself! Quote Retweet this post with your favorite playable member of the Intelligentsia Guild. If it isn't Dr. Ratio, you better have a good explanation. A total of 20 winners will be drawn. Remember to include the hashtags #HonkaiStarRail and #DrRatio for a chance to win. Attention: 1. The list of winners will be revealed in the comments section of this post 2 weeks after the conclusion of this event so keep an eye on this post!
46
Great job Kris! Impact of Patient Visualization of Cardiovascular Images on Modificati... sciencedirect.com/science/ar…
35
I'd like to share this interesting meta-analysis study of RCTs collaborating with sepecialists in infectious disease, cardiology, and lipidology - in which we found no association of PCSK9 inhibitor use with sepsis and other adverse infections – amjmed.com/article/S0002-934…
64
Congratulations Mark! Very well deserved! 🏅🏅🏅
Congrats @ResearchMenzies based Chief investigator to #ASPREE, Mark Nelson, awarded for his research 'LDL-C and mortality outcomes amongst healthy older adults not taking lipid-lowering agents' presented at #GP22 #ASPREEdata #longitudinalstudies #olderadults #olderpeople #lipids
Very important study led by my colleague Chao investigating the comparative net effects of three DMTs for patients with RRMS.@MonashCCS Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis jnnp.bmj.com/content/early/2…
1
Worth reading!
1 of best written editorial from maestro @RonBlankstein #Chandrashekhar @JACCJournals read in recent yrs a guide how to approach complex issues accounting uncertainties/data vs limiting to mere soundbites using example "CAC in Symptomatic pts: Can Data Settle the Debate?"👇
2
Super thrilled to receive a 2022 Postdoctoral Fellowship from the @heartfoundation!🤩I look forward to continuing working with the ASPREE team @aspree_org on the project targeting the prognostic implication of cholesterol in primary prevention older populations. @ResearchMenzies
We're excited to announce our 2022 research funding portfolio! The Heart Foundation will be supporting 59 research projects, investing a total of $13.25 million into fighting the no.1 cause of death in Australia - heart disease. Read more about the projects and recipients 👇

3
2
1
22
I sleep 9 hours everyday and have been thinking it is too long. Now this reassures me. People who sleep 7-9 hours get full points. Hoo-yay. Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep medpagetoday.com/cardiology/…
The Impending Crisis of Access to Safe Abortion Care in the US ja.ma/3ytPKrv via @JAMAInternalMed part of @JAMANetwork